Procter & Gamble CoPG:NYQ

92.05
0.05 / 0.05%
14.04m
12.39%
0.373
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Dec 19 2014 21:05 GMT.

Consensus recommendation

As of Dec 20, 2014, the consensus forecast amongst 32 polled investment analysts covering Procter & Gamble Co advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on May 20, 2009. The previous consensus forecast advised investors to hold their position in Procter & Gamble Co.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy9
Outperform7
Hold14
Underperform1
Sell0
No opinion0

Share price forecast

The 19 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 91.00, with a high estimate of 105.00 and a low estimate of 73.00. The median estimate represents a -1.14% decrease from the last price of 92.05. View Full Financials

High+14.1 %105.00
Med-1.1 %91.00
Low-20.7 %73.00

Dividends

In 2014, Procter & Gamble Co reported a dividend of 2.45 USD, which represents a 7.02% increase over last year. The 15 analysts covering the company expect dividends of 2.59 USD for the upcoming fiscal year, an increase of 5.80%. View Full Financials

Div growth (TTM)+7.02%
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Oct 24, 2014, Procter & Gamble Co reported 1st quarter 2015 earnings of 1.07 per share. This result was in line with the consensus of the 21 analysts following the company and exceeded last year's 1st quarter results by 1.90%.
The next earnings announcement is expected on Jan 27, 2015. View Full Interim Financials

Average growth rate+1.29%

Procter & Gamble Co reported annual 2014 earnings of 4.22 per share on Aug 01, 2014. View Full Annual Financials

Average growth rate+0.74%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

The Procter & Gamble Company had 1st quarter 2015 revenues of 20.8bn. This missed the 20.8bn consensus estimate of the 19 analysts following the company. This was 3.15% above the prior year's 1st quarter results. View Full Interim Financials

Average growth rate-0.36%

The Procter & Gamble Company had revenues for the full year 2014 of 83.1bn. This was 1.31% below the prior year's results. View Full Annual Financials

Average growth rate+1.30%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.